End-2014, MedLife said it targets investments of over EUR10 million in greenfield projects and new acquisitions, as well as a turnover of EUR100 million in 2015.
As regards the medical subscription market, MedLife said it reached a total 320,000 subscribers countrywide last year, 16.5% more against 2013, exceeding a 45% market share. For 2015, the company targets a 20% increase, double compared to the growth rate of the profile market.
Mirela Dogaru took over as corporate manager in November 2014 and her main business objective is the accelerated expansion of the company’s subscriber portfolio, mainly at regional level.
Early 2015, MedLife bought a 55% stake in the group of firms Centrul Medical SAMA and Ultratest, one of the largest medical operators in southwestern Romania, with operations in Craiova, Ramnicu Valcea, Slatina, Calafat and Balcesti.
MedLife has been operating on the Romanian market since 1996. It currently has 13 clinics, ten laboratories, six hospitals, 30 GP medical centers, seven PharmaLife Med drugstores and partnerships with 135 medical clinics across the country.
The company is owned by the Marcu family with 51%, SGAM Eastern Europe, owned by a subsidiary of Societe Generale, with 36.25%, and IFC, part of the World Bank Group, with 12.75%.